Search company, investor...

DermaGen

dermagen.se

Founded Year

2004

Stage

Other Investors | Alive

About DermaGen

DermaGen develops peptide therapeutics for topical use based on antimicrobial peptides (AMPs).

Headquarters Location

Hallestad 591

240 10,

Sweden

Missing: DermaGen's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: DermaGen's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

DermaGen Patents

DermaGen has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/15/2007

7/24/2012

Antimicrobial peptides, Protein families, Antibiotics, Immune system

Grant

Application Date

5/15/2007

Grant Date

7/24/2012

Title

Related Topics

Antimicrobial peptides, Protein families, Antibiotics, Immune system

Status

Grant

DermaGen Frequently Asked Questions (FAQ)

  • When was DermaGen founded?

    DermaGen was founded in 2004.

  • What is DermaGen's latest funding round?

    DermaGen's latest funding round is Other Investors.

  • Who are the investors of DermaGen?

    Investors of DermaGen include Midroc Invest, Karolinska Development and Lunds Universitets Innovation System.

  • Who are DermaGen's competitors?

    Competitors of DermaGen include ISA Pharmaceuticals, OcuNexus Therapeutics, Rhythm Pharmaceuticals, Tarsa Therapeutics, Anacor Pharmaceuticals and 11 more.

Compare DermaGen to Competitors

A
AI2

AI2 is a spin-out from the Faculty of Life Sciences. The company has peptide technology which it is developing for a range of antimicrobial coating and therapeutic applications.

I
Intarcia Therapeutics

Intarcia Therapeutics is a biopharmaceutical company based in Boston, Massachusetts. Intarcia is engaged in the development of a pipeline of products for the proprietary Medici Drug Delivery System comprised of three technologies: A stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures, a matchstick-sized osmotic mini-pump that is placed under the dermal layer of skin to deliver a continuous and consistent flow of medication, and a placement technology including proprietary tools designed to provide an optimal user experience.

I
Isogenica

Isogenica specializes in the discovery and optimization of therapeutic and diagnostic peptides, proteins and antibodies. The company has an exclusive license to in vitro display technology that allows the generation of polypeptide and antibody libraries from which it is possible to select lead molecules with high affinity and specificity for most targets.

A
Actinobac Biomed

Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon Leukothera (LtxA), a natural protein that targets and eliminates white blood cells (WBCs) involved in the mechanism of many diseases. Products based upon Leukothera are being developed by Actinobac for the treatment of leukemia/lymphoma, dry eye, and psoriasis.

A
Aderis Pharmaceuticals

Aderis Pharmaceuticals, formerly Discovery Therapeutics, develops and commercializes small molecule, receptor-specific therapeutics for the treatment of central nervous system, cardiovascular and renal diseases.

CoImmune Logo
CoImmune

CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Using biological components from each patient, the company's immunotherapies employ the patient's dendritic cells to activate an immune response specific to the patient's disease.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.